CAR T cells are created by extracting T cells from a patient’s blood, genetically engineering them to express CARs, and then expanding these modified cells in the laboratory. The process involves isolating the T cells, using a viral vector to introduce the CAR gene, and culturing the cells to increase their numbers. Once prepared, the modified T cells are infused back into the patient.
